141 related articles for article (PubMed ID: 8531178)
21. Assessment of changes in hemostatic markers in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
Tarnow I; Kristensen AT; Olsen LH; Pedersen HD
Am J Vet Res; 2004 Dec; 65(12):1644-52. PubMed ID: 15631028
[TBL] [Abstract][Full Text] [Related]
22. Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions.
Pedersen HD; Olsen LH; Mow T; Christensen NJ
Res Vet Sci; 1999 Feb; 66(1):11-7. PubMed ID: 10088706
[TBL] [Abstract][Full Text] [Related]
23. Decreased platelet function in Cavalier King Charles Spaniels with mitral valve regurgitation.
Tarnow I; Kristensen AT; Texel H; Olsen LH; Pedersen HD
J Vet Intern Med; 2003; 17(5):680-6. PubMed ID: 14529135
[TBL] [Abstract][Full Text] [Related]
24. Dogs with heart diseases causing turbulent high-velocity blood flow have changes in platelet function and von Willebrand factor multimer distribution.
Tarnow I; Kristensen AT; Olsen LH; Falk T; Haubro L; Pedersen LG; Pedersen HD
J Vet Intern Med; 2005; 19(4):515-22. PubMed ID: 16095168
[TBL] [Abstract][Full Text] [Related]
25. Aldosterone breakthrough in dogs with naturally occurring myxomatous mitral valve disease.
Ames MK; Atkins CE; Eriksson A; Hess AM
J Vet Cardiol; 2017 Jun; 19(3):218-227. PubMed ID: 28576479
[TBL] [Abstract][Full Text] [Related]
26. Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.
Reimann MJ; Møller JE; Häggström J; Martinussen T; Zatrazemi SSC; Svanholm L; Nielsen LBM; Pedersen HD; Olsen LH
J Vet Intern Med; 2017 Jul; 31(4):1008-1016. PubMed ID: 28573754
[TBL] [Abstract][Full Text] [Related]
27. Serum serotonin concentrations in dogs with degenerative mitral valve disease.
Arndt JW; Reynolds CA; Singletary GE; Connolly JM; Levy RJ; Oyama MA
J Vet Intern Med; 2009; 23(6):1208-13. PubMed ID: 19709352
[TBL] [Abstract][Full Text] [Related]
28. Plasma renin activity and aldosterone concentration in dogs with acquired portosystemic collaterals.
Sakamoto Y; Sakai M; Sato K; Watari T
J Vet Intern Med; 2020 Jan; 34(1):139-144. PubMed ID: 31729111
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary blood volume in mitral regurgitation in Cavalier King Charles spaniels.
Eriksson A; Hansson K; Häggström J; Järvinen AK; Lord P
J Vet Intern Med; 2010; 24(6):1393-9. PubMed ID: 20958790
[TBL] [Abstract][Full Text] [Related]
30. Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
Pouchelon JL; Jamet N; Gouni V; Tissier R; Serres F; Carlos Sampedrano C; Castaignet M; Lefebvre HP; Chetboul V
J Vet Intern Med; 2008; 22(4):905-14. PubMed ID: 18482278
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of mitral valve insufficiency in cavalier King Charles spaniels.
Malik R; Hunt GB; Allan GS
Vet Rec; 1992 Apr; 130(14):302-3. PubMed ID: 1595150
[No Abstract] [Full Text] [Related]
32. Changes in renin-angiotensin-aldosterone system during cardiac remodeling after mitral valvuloplasty in dogs.
Cheng CJ; Mandour AS; Yoshida T; Watari T; Tanaka R; Matsuura K
J Vet Intern Med; 2022 Mar; 36(2):397-405. PubMed ID: 34994485
[TBL] [Abstract][Full Text] [Related]
33. Body size, but neither age nor asymptomatic mitral regurgitation, influences plasma concentrations of dimethylarginines in dogs.
Pedersen LG; Tarnow I; Olsen LH; Teerlink T; Pedersen HD
Res Vet Sci; 2006 Jun; 80(3):336-42. PubMed ID: 16182327
[TBL] [Abstract][Full Text] [Related]
34. Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs.
Tidholm A; Häggström J; Hansson K
Am J Vet Res; 2001 Jun; 62(6):961-7. PubMed ID: 11400857
[TBL] [Abstract][Full Text] [Related]
35. C-reactive protein concentration in dogs with chronic valvular disease.
Rush JE; Lee ND; Freeman LM; Brewer B
J Vet Intern Med; 2006; 20(3):635-9. PubMed ID: 16734101
[TBL] [Abstract][Full Text] [Related]
36. Circulating concentrations of insulin-like growth factor-1 in dogs with naturally occurring mitral regurgitation.
Pedersen HD; Falk T; Häggström J; Tarnow I; Olsen LH; Kvart C; Nielsen MO
J Vet Intern Med; 2005; 19(4):528-32. PubMed ID: 16095170
[TBL] [Abstract][Full Text] [Related]
37. Circulating MiR-30b-5p is upregulated in Cavalier King Charles Spaniels affected by early myxomatous mitral valve disease.
Bagardi M; Ghilardi S; Zamarian V; Ceciliani F; Brambilla PG; Lecchi C
PLoS One; 2022; 17(7):e0266208. PubMed ID: 35816500
[TBL] [Abstract][Full Text] [Related]
38. Chronic mitral valve disease in cavalier King Charles spaniels: 95 cases (1987-1991).
Beardow AW; Buchanan JW
J Am Vet Med Assoc; 1993 Oct; 203(7):1023-9. PubMed ID: 8135932
[TBL] [Abstract][Full Text] [Related]
39. Predictive value of natriuretic peptides in dogs with mitral valve disease.
Tarnow I; Olsen LH; Kvart C; Hoglund K; Moesgaard SG; Kamstrup TS; Pedersen HD; Häggström J
Vet J; 2009 May; 180(2):195-201. PubMed ID: 18675567
[TBL] [Abstract][Full Text] [Related]
40. Intermittent mitral regurgitation in Cavalier King Charles spaniels: Short-term progression and influence of stress tests.
Reimann MJ; Møller JE; Häggström J; Åkerström LLB; Martinussen T; Olsen LH
Vet J; 2020 Apr; 258():105457. PubMed ID: 32564867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
